Skip to main content
Erschienen in: BMC Pregnancy and Childbirth 1/2022

Open Access 01.12.2022 | Correction

Correction: Do maternal albumin levels affect post-operative complications after cesarean delivery?

verfasst von: Yael Yagur, Rachel Ribak, Emili Ben Ezry, Ido Cohen, Libby Or Madar, Michal Kovo, Tal Biro

Erschienen in: BMC Pregnancy and Childbirth | Ausgabe 1/2022

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Hinweise
The original article can be found online at https://​doi.​org/​10.​1186/​s12884-022-05215-8.
Correction: BMC Pregnancy Childbirth 22, 909 (2022)
https://doi.org/10.1186/s12884-022-05215-8
Following the publication of the original article [1], it was noted that due to a typesetting error the heading of the second column of Tables 1 and 2 should read “Serum albumin level < 3.3 (n = 250).
Table 1
Demographic characteristics of the study groups
Characteristic
Serum albumin level < 3.3 (n = 250)
Serum albumin level ≥ 3.3 (n = 287)
P-value
Age (years)
34.4 ± 5.3
33.7 ± 5.3
0.15
Ethnicity
 Jewish
189 (74.4%)
229 (80.1%)
0.14
 Muslim
63 (25.3%)
57 (19.9%)
Cesarean delivery
 No previous CD
66 (26.4%)
56 (19.5%)
 
 One previous CD
98 (39.2%)
113 (39.4%)
0.11
 More than one previous CD
86 (34.4%)
118 (41.1%)
 
Diabetes mellitus
40 (16.1%)
50 (17.7%)
0.62
Smoker
13 (5.3%)
18 (6.4%)
0.60
BMI (kg/m2)
 BMI < 25
130 (57%)
175 (67.3%)
0.02
 BMI ≥25
98 (43%)
85 (32.7%)
Primigravida
43 (17.2%)
29 (10.1%)
0.02
Laboratory tests at admission
 Hemoglobin (g/dl)
11.3 ± 1.2
11.8 ± 1.1
< 0.001
 Hematocrit (%)
33.9 ± 3.9
35.2 ± 3.2
< 0.001
 White blood cells (K/microL)
8.9 ± 2.3
9.4 ± 2.1
0.009
 Platelets (K/microL)
207.1 ± 59
209.1 ± 53.6
0.68
 Total protein (g/dl)
6.2 ± 0.4
6.8 ± 0.3
0.007
 Cholesterol (mg/dL)
262.9 ± 55.1
279.5 ± 57
0.001
Neonatal birth-weight (g)
3149 ± 516
3197 ± 536
0.27
Data are shown as number (%), mean ± standard deviation or median (range), as appropriate; GDMA1-gestational diabetes mellitus A1; GDMA2-gestational diabetes mellitus A2; BMI-body mass index (kg/m2)
Table 2
Post-partum maternal morbidity
Variable
Serum albumin level < 3.3 (n = 250)
Serum albumin level ≥ 3.3 (n = 287)
P-value
Duration of hospitalization (days)
3.1 ± 0.4
3.0 ± 0.3
0.08
Rehospitalization rate
1 (0.4%)
15 (5.2%)
0.001
Surgical site infection
4 (1.6%)
16 (5.6%)
0.02
Positive blood culture
1 (0.6%)
7 (3.4%)
0.05
Antibiotic treatment
8 (3.2%)
31 (10.8%)
0.001
Surgical intervention
0 (0%)
6 (2.1%)
0.03
Laboratory tests post operative
 Hemoglobin (g/dl)
10.4 ± 1.3
10.7 ± 1.3
0.003
 White blood cells (K/microL)
10.1 ± 2.5
10.6 ± 2.5
0.04
 Platelets (K/microL)
192.2 ± 55.2
194.8 ± 53.6
0.6
Need for blood transfusion
2 (0.8%)
3 (1.1%)
1
Data are shown as number (%), mean ± standard deviation or median (range), as appropriate
The correct tables have been included in this correction, and the original article has been corrected.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Correction: Do maternal albumin levels affect post-operative complications after cesarean delivery?
verfasst von
Yael Yagur
Rachel Ribak
Emili Ben Ezry
Ido Cohen
Libby Or Madar
Michal Kovo
Tal Biro
Publikationsdatum
01.12.2022
Verlag
BioMed Central
Erschienen in
BMC Pregnancy and Childbirth / Ausgabe 1/2022
Elektronische ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-022-05313-7

Weitere Artikel der Ausgabe 1/2022

BMC Pregnancy and Childbirth 1/2022 Zur Ausgabe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.